Novo Nordisk’s weight-loss drug Wegovy launches in PHL

Novo Nordisk’s launch of Wegovy in the Philippines represents a significant innovation in obesity management, leveraging semaglutide’s GLP-1 receptor agonist mechanism to address metabolic challenges, with material science advancements in drug formulation and delivery systems playing a critical role in its efficacy and scalability for diverse patient populations.

Edward Lance Arellano Lorilla

CEO / Co-Founder

Enjoy the little things in life. For one day, you may look back and realize they were the big things. Many of life's failures are people who did not realize how close they were to success when they gave up.